We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
FMC Corp (FMC) Teams Up With AgroSpheres for Bioinsecticides
Read MoreHide Full Article
FMC Corporation (FMC - Free Report) recently entered into a research partnership with AgroSpheres, a biotechnology firm dedicated to sustainable crop protection and health. This collaboration is geared toward expediting the discovery and advancement of groundbreaking bioinsecticides, aligning with FMC's strategic goals.
The agreement is aimed at solidifying FMC's leadership position in insecticide solutions while also expediting AgroSpheres' introduction of its ribonucleic acid (RNA) portfolio to the market. By leveraging AgroSpheres' expertise in production and formulation alongside FMC's robust testing, evaluation and market deployment capabilities, both parties aim to achieve significant strides in their shared objectives.
FMC's investment in AgroSpheres, which is developing its biodegradable micro-encapsulation technology designed to enhance the efficacy of biological crop protection products using RNA interference (RNAi) technology, paved the way for this collaboration.
FMC underscored the collaboration's importance in driving sustainable agriculture through innovation. It hailed RNAi as a promising tool for crop protection and commended AgroSpheres' platform for its efficient discovery and manufacturing of these technologies.
AgroSpheres' patented AgriCell manufacturing technology enables the consistent expression of various RNA molecules, effectively tackling challenges encountered in commercial biological development. Their encapsulated RNA biomolecules promise improved stability, performance and targeted uptake in pests.
AgroSpheres expressed admiration for FMC's proactive stance in investing in next-generation agricultural technologies to address global challenges. The company looks forward to collaborating with FMC to drive comprehensive product development, leveraging their collective expertise to meet market demands effectively.
FMC’s shares have plunged 39.4% in the past year against a 0.9% rise of the industry.
Image Source: Zacks Investment Research
FMC sees full-year 2024 revenues between $4.50 billion and $4.70 billion, indicating a 2.5% increase at the midpoint from 2023 levels. Adjusted EBITDA is expected to be between $900 million to $1.05 billion, flat at the midpoint compared with the prior year’s levels. Adjusted earnings are forecast in the range of $3.23 to $4.41 per share, up 1% year over year at the midpoint.
ATI’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 8.34%. The company’s shares have soared 64.7% in the past year.
CRS’ earnings beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, with the average earnings surprise being 15.1%. The company’s shares have soared 106%% in the past year.
The Zacks Consensus Estimate for Ecolab's current year earnings is pegged at $6.59 per share, indicating a year-over-year rise of 26.5%. The Zacks Consensus Estimate for ECL’s current-year earnings has been going up in the past 30 days. ECL beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 1.3%. The stock has rallied nearly 33.4% in the past year.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
FMC Corp (FMC) Teams Up With AgroSpheres for Bioinsecticides
FMC Corporation (FMC - Free Report) recently entered into a research partnership with AgroSpheres, a biotechnology firm dedicated to sustainable crop protection and health. This collaboration is geared toward expediting the discovery and advancement of groundbreaking bioinsecticides, aligning with FMC's strategic goals.
The agreement is aimed at solidifying FMC's leadership position in insecticide solutions while also expediting AgroSpheres' introduction of its ribonucleic acid (RNA) portfolio to the market. By leveraging AgroSpheres' expertise in production and formulation alongside FMC's robust testing, evaluation and market deployment capabilities, both parties aim to achieve significant strides in their shared objectives.
FMC's investment in AgroSpheres, which is developing its biodegradable micro-encapsulation technology designed to enhance the efficacy of biological crop protection products using RNA interference (RNAi) technology, paved the way for this collaboration.
FMC underscored the collaboration's importance in driving sustainable agriculture through innovation. It hailed RNAi as a promising tool for crop protection and commended AgroSpheres' platform for its efficient discovery and manufacturing of these technologies.
AgroSpheres' patented AgriCell manufacturing technology enables the consistent expression of various RNA molecules, effectively tackling challenges encountered in commercial biological development. Their encapsulated RNA biomolecules promise improved stability, performance and targeted uptake in pests.
AgroSpheres expressed admiration for FMC's proactive stance in investing in next-generation agricultural technologies to address global challenges. The company looks forward to collaborating with FMC to drive comprehensive product development, leveraging their collective expertise to meet market demands effectively.
FMC’s shares have plunged 39.4% in the past year against a 0.9% rise of the industry.
Image Source: Zacks Investment Research
FMC sees full-year 2024 revenues between $4.50 billion and $4.70 billion, indicating a 2.5% increase at the midpoint from 2023 levels. Adjusted EBITDA is expected to be between $900 million to $1.05 billion, flat at the midpoint compared with the prior year’s levels. Adjusted earnings are forecast in the range of $3.23 to $4.41 per share, up 1% year over year at the midpoint.
FMC Corporation Price and Consensus
FMC Corporation price-consensus-chart | FMC Corporation Quote
Zacks Rank & Key Picks
FMC currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are ATI Inc. (ATI - Free Report) and Carpenter Technology Corporation (CRS - Free Report) , each sporting a Zacks Rank #1 (Strong Buy), and Ecolab Inc. (ECL - Free Report) , carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
ATI’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 8.34%. The company’s shares have soared 64.7% in the past year.
CRS’ earnings beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, with the average earnings surprise being 15.1%. The company’s shares have soared 106%% in the past year.
The Zacks Consensus Estimate for Ecolab's current year earnings is pegged at $6.59 per share, indicating a year-over-year rise of 26.5%. The Zacks Consensus Estimate for ECL’s current-year earnings has been going up in the past 30 days. ECL beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 1.3%. The stock has rallied nearly 33.4% in the past year.